Significance of dihydropyrimidine dehydrogenase activity in renal cell carcinoma

By Mizutani Y.   Wada H.   Yoshida O.   Fukushima M.   Nakanishi H.   Nakao M.   Miki T.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 541-547

Elsevier

Access to resources Recommend Favorite

Clinical Significance of Intratumoral TS Levels and DPD Activity in Breast Cancer

By Miyashita Masaru   Yoshimura Hisashi   Hatta Ken   Tachibana Shiro   Kubota Maki   Takahashi Hiroshi   Yamazaki Yoshisada   Maeda Kousaku   Okita Yutaka   Takao Shintaro  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 407-411

Sunmedia

Access to resources Recommend Favorite

Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyridine (CDHP) in human tumour cells

By Takechi T.   Fujioka A.   Matsushima E.   Fukushima M.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1271-1277

Elsevier

Access to resources Recommend Favorite

La dihydropyrimidine déshydrogénase (DPD)

By Gamelin E.   Boisdron-Celle M.   Morel A.  

Oncologie, Vol. 16, Iss. 2-3, 2014-02 ,pp. : 96-102

Springer Publishing Company

Access to resources Recommend Favorite

Thymidylate synthetase and dihydropyrimidine dehydrogenase mRNA levels in esophageal cancer

By Kimura Masahiro   Kuwabara Yoshiyuki   Mitsui Akira   Ishiguro Hideyuki   Sugito Nobuyoshi   Tanaka Tatsuya   Shiozaki Midori   Naganawa Yasuhiro   Takeyama Hiromitsu  

Oncology Letters, Vol. 2, Iss. 2, 2011-03 ,pp. : 297-301

Spandidos Publications

Access to resources Recommend Favorite